Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Veritone Inc

Start price
Target price
Perf. (%)
€10.44
30.04.22
€5.00
30.04.23
-18.64%
14.05.22

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Sword Group

Start price
Target price
Perf. (%)
€37.80
30.04.22
€20.00
30.04.23
1.32%
14.05.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Accolade Inc.

Start price
Target price
Perf. (%)
€5.30
30.04.22
€2.00
30.04.23
7.55%
14.05.22

Little innovation
Growths slower than the competition
high free float
Significant cyclical dependencies
Toughbuilt Industries Inc.

Start price
Target price
Perf. (%)
€11.73
30.04.22
€5.00
30.04.23
-33.65%
14.05.22

Light S.A. ADR 1

Start price
Target price
Perf. (%)
€1.39
30.04.22
€0.000
30.04.23
-17.27%
14.05.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Ev Technology Group Ltd.

Start price
Target price
Perf. (%)
€0.99
30.04.22
€0.000
30.04.23
-23.06%
14.05.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Marrone Bio Inn.

Start price
Target price
Perf. (%)
€1.13
30.04.22
€0.000
30.04.23
-18.58%
14.05.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Pittler Maschinenfabrik AG

Start price
Target price
Perf. (%)
€3.10
30.04.22
€1.00
30.04.23
-19.35%
14.05.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
MOL plc ADR

Start price
Target price
Perf. (%)
€3.56
30.04.22
€2.00
30.04.23
-11.80%
14.05.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Park & Bellheimer AG

Start price
Target price
Perf. (%)
€1.66
29.04.22
-
29.04.23
8.43%
30.04.23

buy
Siltronic AG

Start price
Target price
Perf. (%)
€89.95
29.04.22
€120.00
29.04.23
-27.29%
30.04.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
buy
Zymeworks Delaware Inc.

Start price
Target price
Perf. (%)
€7.24
29.04.22
-
29.04.23
-18.78%
30.04.22

Risky Investment
buy
Artec Technologies

Start price
Target price
Perf. (%)
€2.42
29.04.22
€3.10
29.04.23
-22.31%
29.04.23

buy
BASF SE

Start price
Target price
Perf. (%)
€50.82
29.04.22
€60.00
29.04.23
1.56%
02.05.22

Could be worthwhile Investment >10% per year
buy
Henkel AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€58.44
29.04.22
€65.00
29.04.23
4.24%
02.05.22

Could be worthwhile Investment >10% per year
buy
First Graphite Ltd.

Start price
Target price
Perf. (%)
€0.11
29.04.22
-
29.04.23
-52.88%
29.04.23

buy
Seagate Technology.Holdings plc

Start price
Target price
Perf. (%)
€78.28
28.04.22
-
28.04.23
-27.87%
21.10.22

Could be worthwhile Investment >10% per year
buy
Bank of America Corp.

Start price
Target price
Perf. (%)
€35.03
28.04.22
€40.00
01.09.22
0.19%
22.08.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Coca-Cola Co.

Start price
Target price
Perf. (%)
€62.88
28.04.22
€54.00
28.04.23
-6.79%
29.04.23

Small Risks for its business
Market Leader or Top 3
Well known brand
Undervalued
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.52
28.04.22
-
28.04.23
-2.36%
30.04.22

Risky Investment
buy
Alpha+omega Semiconductor

Start price
Target price
Perf. (%)
€41.97
28.04.22
-
28.04.23
-46.53%
29.04.23

Could be worthwhile Investment >10% per year
Coinbase Global Inc.

Start price
Target price
Perf. (%)
€120.02
28.04.22
€100.00
28.04.23
-47.56%
23.05.22

Could be worthwhile Investment >10% per year
Below average Marketposition
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.37
28.04.22
€2.00
28.04.23
0.74%
03.08.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
BioNTech SE ADR

Start price
Target price
Perf. (%)
€137.95
28.04.22
€120.00
28.04.23
12.54%
23.05.22

Good rating
Medium risks for its business
Very low/no dividend yield expected
high free float
Teladoc Health Inc

Start price
Target price
Perf. (%)
€30.77
28.04.22
€25.00
28.04.23
19.70%
03.05.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand